Brachytherapy of 125I implantation for localized prostate cancer (report of 41 cases).
- Author:
Qiang BAI
1
;
Yixin WANG
;
Keith W KAYE
Author Information
- Publication Type:Journal Article
- MeSH: Aged; Aged, 80 and over; Brachytherapy; adverse effects; methods; Humans; Iodine Radioisotopes; therapeutic use; Male; Middle Aged; Prostatic Neoplasms; mortality; radiotherapy; Survival Rate
- From: National Journal of Andrology 2004;10(5):371-373
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo observe the effect of brachytherapy of 125I implantation on localized prostate cancer.
METHODSTwo-step technique was engaged in the implantation of 125I into the prostate for 41 localized prostate cancer patients. The prescription dosage of 125I was 160 Gy. TRUS and C-Arm X-ray were used for the confirmation of seeds location in the prostate.
RESULTSThirty-three patients were followed up for 3 to 4 years. Abnormal PSAs were found in 2 patients by positive biopsy. No patients died in this investigation. The early stage complications were urinary irritation symptoms that were severe within 6 months and disappeared after 1 year.
CONCLUSIONBrachytherapy of 125I implantation increases long-term tumor-free survival rate, with few long-term complications and some short-tern urinary stimulating symptoms.
